- Home
- SWZ vs VERU Comparison
SWZ vs VERU Comparison
Compare SWZ & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWZ
- VERU
- Stock Information
- Founded
- SWZ 1986
- VERU 1971
- Country
- SWZ United States
- VERU United States
- Employees
- SWZ N/A
- VERU N/A
- Industry
- SWZ Finance Companies
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- SWZ Finance
- VERU Health Care
- Exchange
- SWZ Nasdaq
- VERU Nasdaq
- Market Cap
- SWZ 79.1M
- VERU 85.5M
- IPO Year
- SWZ N/A
- VERU 1990
- Fundamental
- Price
- SWZ $6.12
- VERU $3.60
- Analyst Decision
- SWZ
- VERU Strong Buy
- Analyst Count
- SWZ 0
- VERU 3
- Target Price
- SWZ N/A
- VERU $33.33
- AVG Volume (30 Days)
- SWZ 14.2K
- VERU 227.8K
- Earning Date
- SWZ 01-01-0001
- VERU 08-12-2025
- Dividend Yield
- SWZ 6.59%
- VERU N/A
- EPS Growth
- SWZ N/A
- VERU N/A
- EPS
- SWZ N/A
- VERU N/A
- Revenue
- SWZ N/A
- VERU $16,886,419.00
- Revenue This Year
- SWZ N/A
- VERU N/A
- Revenue Next Year
- SWZ N/A
- VERU N/A
- P/E Ratio
- SWZ N/A
- VERU N/A
- Revenue Growth
- SWZ N/A
- VERU 337.24
- 52 Week Low
- SWZ $7.12
- VERU $2.64
- 52 Week High
- SWZ $8.57
- VERU $14.20
- Technical
- Relative Strength Index (RSI)
- SWZ 46.11
- VERU 36.46
- Support Level
- SWZ $6.03
- VERU $2.64
- Resistance Level
- SWZ $6.20
- VERU $3.98
- Average True Range (ATR)
- SWZ 0.06
- VERU 0.40
- MACD
- SWZ 0.00
- VERU 0.03
- Stochastic Oscillator
- SWZ 44.74
- VERU 42.48
About SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, Semiconductors, Information Technology, and retail.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.